Barclays raised the firm’s price target on 3M to $111 from $110 and keeps an Equal Weight rating on the shares. The analyst says that while the Solventum spin could yield a re-rating higher, dividend re-basing may weigh on the shares in the short-term.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MMM:
- 3M board approves spinoff of Solventum, sets April 1 distribution date
- 3M, HD Hyundai KSOE collaborate on research project for liquid hydrogen storage
- 3M price target lowered to $84 from $85 at RBC Capital
- 3M announces filing of Form 10 for planned spinoff of health care business
- 3M price target raised to $118 from $108 at JPMorgan
